Jehan Fouad Helmi, MD
Neuropsychiatry · Folsom
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 6
- 3 carriers
- Offices
- 5
Offices
5 locations · Hisham Soliman MD Inc · Hazel Hawkins Memorial Hospital · St. Helena Hospital · Foundations Behavioral Health Services Inc · Ohioguidestone
Plans that list them
6 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Helmi’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
6 of 6 plans
| Advantage Care (HMO) | Align Senior Care | Listed | Oct 1, 2026 |
| Premier Care (HMO I-SNP) | Align Senior Care | Listed | Oct 1, 2026 |
| Senior Care (HMO I-SNP) | Align Senior Care | Listed | Oct 1, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A124839 · Current
Licensed to practise in California · since 2013 · expires 2027-02-28 · King Abdul Aziz University College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$5,472
Medicare paid this office $5,472 for 29 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 20 | $3,155 | $70 |
| Telehealth originating site facility fee | 16 | $682 | $22 |
Who their Medicare patients are
29 Original Medicare patients in 2024. Average age 53 · Women 38% · Health risk score 1.24. At or below the middle of the specialty; the typical psychiatry clinician is at 1.35.
Conditions among them: High blood pressure 66% · Depression 48% · Diabetes 38%.
The office billed $11,914, Medicare allowed $7,162 and paid $5,472; for 93 services of 7 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 29 | 93 | 53 | 1.24 | $11,914 | $5,472 |
| 2023 | 31 | 59 | 48 | 1.26 | $20,113 | $4,009 |
| 2022 | 37 | 147 | 52 | 0.91 | $44,591 | $11,361 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 1 service
| Return visit (30+ min) | 24 | $1,727 | $49 |
2022: 2 services
| Return visit (30+ min) | 27 | $4,277 | $81 |
| Psychiatric diagnostic evaluation with medical services | 11 | $1,578 | $143 |
Medicaid work
$396,953 in 2024
Medicaid paid $396,953 for 914 billed services this clinician did in 2024, up to 81 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Assertive community treatment program, per diem | 500 | $338,777 |
| Long return visit (40+ min) | 298 | $46,858 |
| Return visit (30+ min) | 116 | $11,318 |
| 2024 | 914 | 3 | 81 | $396,953 |
| 2023 | 757 | 4 | 49 | $24,698 |
| 2022 | 152 | 3 | 21 | $6,495 |
| 2021 | 220 | 4 | 30 | $19,056 |
See the largest Medicaid services in earlier years
2023
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 569 | $16,729 |
| Hospital inpatient or observation discharge day management; more than 30 minutes on the date of the encounter | 108 | $3,551 |
| 1ST HOSP IP/OBS HIGH 75 | 46 | $2,689 |
| New patient visit (60+ min) | 34 | $1,728 |
2022
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 87 | $2,900 |
| 1ST HOSP IP/OBS HIGH 75 | 42 | $2,843 |
| Hospital inpatient or observation discharge day management; more than 30 minutes on the date of the encounter | 23 | $752 |
2021
| Return visit (30+ min) | 98 | $8,858 |
| Long return visit (40+ min) | 42 | $4,817 |
| Psychotherapy, 30 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure) | 64 | $3,344 |
| Psychiatric diagnostic evaluation with medical services | 16 | $2,037 |
Drugs they prescribed that Part D paid
$264,295
Pharmacies billed $264,295 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,415) in 2024. At or below the middle of the specialty; the typical psychiatry clinician is at 0%.
1,305 generic and fewer than 11 brand-name prescriptions · $264,295 in drug cost · 46 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Invega Sustenna | 30 | $104,408 | $3,480 |
| Abilify Maintena | 23 | $69,434 | $3,019 |
| Vraylar | 15 | $22,113 | $1,474 |
| Paliperidone Er | 31 | $7,984 | $258 |
| Aripiprazole | 41 | $4,252 | $104 |
See all 36 drugs
| Invega Sustenna | 30 | $104,408 | $3,480 |
| Abilify Maintena | 23 | $69,434 | $3,019 |
| Vraylar | 15 | $22,113 | $1,474 |
| Paliperidone Er | 31 | $7,984 | $258 |
| Aripiprazole | 41 | $4,252 | $104 |
| Lurasidone | 26 | $3,688 | $142 |
| Dextroamphetamine-Amphet Er | 20 | $2,203 | $110 |
| Mirtazapine | 112 | $1,879 | $17 |
| Divalproex | 44 | $1,839 | $42 |
| Clozapine | 25 | $1,692 | $68 |
| Hydroxyzine | 52 | $1,536 | $30 |
| Oxcarbazepine | 11 | $1,493 | $136 |
| Haloperidol | 30 | $1,233 | $41 |
| Divalproex Sodium Er | 16 | $1,119 | $70 |
| Benztropine Mesylate | 55 | $894 | $16 |
| Bupropion Xl | 44 | $870 | $20 |
| Quetiapine | 50 | $853 | $17 |
| Clonazepam | 56 | $756 | $14 |
| Risperidone | 44 | $742 | $17 |
| Buspirone | 41 | $720 | $18 |
| Trazodone | 70 | $686 | $10 |
| Olanzapine | 14 | $514 | $37 |
| Duloxetine | 30 | $413 | $14 |
| Prazosin | 34 | $407 | $12 |
| Lamotrigine | 45 | $368 | $8 |
| Guanfacine Hcl Er | 16 | $321 | $20 |
| Gabapentin | 21 | $294 | $14 |
| Escitalopram | 40 | $292 | $7 |
| Topiramate | 11 | $218 | $20 |
| Sertraline | 32 | $185 | $6 |
| Propranolol | 15 | $172 | $11 |
| Venlafaxine Hcl Er | 15 | $132 | $9 |
| Hydroxyzine Pamoate | 11 | $123 | $11 |
| Paroxetine | 15 | $122 | $8 |
| Metformin | 11 | $93 | $8 |
| Amitriptyline | 11 | $57 | $5 |
Year by year
| 2024 | 1,415 | 135 | 0% (0) | None | $264,295 |
| 2023 | 2,096 | 156 | 0% (0) | None | $546,701 |
| 2022 | 718 | 92 | 0% (0) | 6% | $90,473 |
| 2021 | 61 | 16 | 0% (0) | None | $5,883 |
| 2018 | 13 | None | 0% (0) | 0% | $277 |
| 2017 | 253 | 19 | 0% (0) | 9% | $34,008 |
| 2016 | 184 | 22 | 0% (0) | 16% | $26,841 |
| 2015 | 20 | None | 0% (0) | None | $3,164 |
| 2014 | 15 | None | 0% (0) | None | $425 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 49 drugs
| Invega Sustenna | 105 | $337,025 | $3,210 |
| Paliperidone Er | 123 | $55,717 | $453 |
| Benztropine Mesylate | 199 | $9,523 | $48 |
| Chlorpromazine | 14 | $8,883 | $634 |
| Olanzapine Odt | 49 | $5,423 | $111 |
| Divalproex | 66 | $5,139 | $78 |
| Quetiapine | 83 | $4,454 | $54 |
| Haloperidol | 47 | $3,801 | $81 |
| Divalproex Sodium Er | 36 | $3,643 | $101 |
| Olanzapine | 50 | $3,609 | $72 |
| Clozapine | 43 | $3,577 | $83 |
| Aripiprazole | 22 | $2,382 | $108 |
| Oxcarbazepine | 14 | $1,742 | $124 |
| Risperidone | 60 | $1,663 | $28 |
| Humulin R | 13 | $1,535 | $118 |
| Mirtazapine | 52 | $1,378 | $26 |
| Gabapentin | 49 | $1,362 | $28 |
| Lorazepam | 46 | $1,308 | $28 |
| Haloperidol Lactate | 14 | $1,256 | $90 |
| Valproic Acid | 13 | $1,060 | $82 |
| Clonazepam | 42 | $949 | $23 |
| Lamotrigine | 60 | $940 | $16 |
| Escitalopram | 38 | $788 | $21 |
| Trazodone | 57 | $782 | $14 |
| Quetiapine Fumarate Er | 15 | $780 | $52 |
| Atorvastatin | 38 | $754 | $20 |
| Haloperidol Decanoate | 13 | $715 | $55 |
| Albuterol Sulfate Hfa | 11 | $589 | $54 |
| Levothyroxine | 40 | $586 | $15 |
| Prazosin | 19 | $541 | $28 |
| Metformin | 40 | $521 | $13 |
| Sertraline | 28 | $512 | $18 |
| Hydroxyzine Pamoate | 21 | $477 | $23 |
| Hydroxyzine | 18 | $466 | $26 |
| Duloxetine | 13 | $458 | $35 |
| Bupropion Xl | 22 | $445 | $20 |
| Lithium Carbonate | 24 | $442 | $18 |
| Amlodipine Besylate | 47 | $436 | $9 |
| Amantadine | 12 | $414 | $34 |
| Propranolol | 18 | $331 | $18 |
| Carbamazepine | 11 | $298 | $27 |
| Fluoxetine | 14 | $253 | $18 |
| Pantoprazole | 19 | $221 | $12 |
| Hydrochlorothiazide | 21 | $197 | $9 |
| Venlafaxine Hcl Er | 11 | $169 | $15 |
| Diphenhydramine | 13 | $154 | $12 |
| Glipizide | 15 | $142 | $9 |
| Omeprazole | 13 | $85 | $7 |
| Lisinopril | 14 | $56 | $4 |
2022: 18 drugs
| Latuda | 11 | $16,621 | $1,511 |
| Paliperidone Er | 23 | $8,642 | $376 |
| Quetiapine | 34 | $1,572 | $46 |
| Clozapine | 19 | $1,542 | $81 |
| Divalproex | 17 | $1,400 | $82 |
| Haloperidol | 17 | $1,183 | $70 |
| Gabapentin | 45 | $1,062 | $24 |
| Benztropine Mesylate | 31 | $894 | $29 |
| Divalproex Sodium Er | 11 | $840 | $76 |
| Olanzapine | 23 | $837 | $36 |
| Trazodone | 57 | $735 | $13 |
| Clonazepam | 28 | $478 | $17 |
| Mirtazapine | 26 | $428 | $16 |
| Risperidone | 19 | $390 | $21 |
| Escitalopram | 34 | $351 | $10 |
| Lamotrigine | 39 | $327 | $8 |
| Hydroxyzine Pamoate | 19 | $256 | $13 |
| Fluoxetine | 17 | $216 | $13 |
2017: 11 drugs
| Quetiapine Fumarate Er | 22 | $10,389 | $472 |
| Clozapine | 22 | $2,692 | $122 |
| Divalproex Sodium Er | 34 | $1,550 | $46 |
| Escitalopram | 18 | $245 | $14 |
| Divalproex | 14 | $228 | $16 |
| Lamotrigine | 14 | $223 | $16 |
| Trazodone | 19 | $99 | $5 |
| Quetiapine | 12 | $77 | $6 |
| Topiramate | 11 | $66 | $6 |
| Metformin | 14 | $61 | $4 |
| Buspirone | 12 | $45 | $4 |
2016: 3 drugs
| Clozapine | 16 | $1,202 | $75 |
| Divalproex | 14 | $232 | $17 |
| Trazodone | 12 | $61 | $5 |
Money from drug and device companies
$1,378 in 2025
| 2025 | 11 | 73 | None | $1,378 |
| 2024 | 5 | 6 | None | $112 |
| 2023 | 1 | 2 | None | $53 |
| 2022 | 1 | 2 | None | $40 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Otsuka America Pharmaceutical | Rexulti | $426 | 23 payments
|
| E.R. Squibb & Sons L.L.C. | Cobenfy | $240 | 16 payments
|
| Teva Pharmaceuticals USA | Austedo Xr | $209 | 7 payments
|
| Abbvie | Vraylar | $180 | 11 payments
|
| Alkermes | Aristada | $85 | 4 payments
|
| Luye Pharma (USA) | Erzofri Extended-Release | $69 | 3 payments
|
See all 73 published payments
| Otsuka America Pharmaceutical | Meals · 2025-12-17 | Abilify Asimtufii | $25 |
| Indivior | Meals · 2025-12-10 | Sublocade | $18 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-12-09 | Cobenfy | $27 |
| Alkermes | Meals · 2025-12-05 | Aristada | $20 |
| Teva Pharmaceuticals USA | Meals · 2025-12-02 | Austedo Xr | $30 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-11-27 | Cobenfy | $27 |
| Neurocrine BioSciences | Meals · 2025-11-25 | Ingrezza | $14 |
| Luye Pharma (USA) | Meals · 2025-11-21 | Erzofri Extended-Release | $18 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-11-17 | Cobenfy | $17 |
| Otsuka America Pharmaceutical | Meals · 2025-11-17 | Abilify Maintena | $18 |
| Alkermes | Meals · 2025-11-14 | Aristada | $21 |
| Otsuka America Pharmaceutical | Meals · 2025-11-11 | Rexulti | $15 |
| Luye Pharma (USA) | Meals · 2025-11-08 | Erzofri Extended-Release | $28 |
| Abbvie | Meals · 2025-11-03 | Vraylar | $21 |
| Neurocrine BioSciences | Meals · 2025-11-03 | Ingrezza | $15 |
| Otsuka America Pharmaceutical | Meals · 2025-10-31 | Rexulti | $20 |
| Otsuka America Pharmaceutical | Meals · 2025-10-24 | Rexulti | $29 |
| Otsuka America Pharmaceutical | Meals · 2025-10-22 | Abilify Asimtufii | $28 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-10-21 | Cobenfy | $12 |
| Alkermes | Meals · 2025-10-20 | Aristada | $17 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-10-17 | Cobenfy | $22 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-10-16 | Cobenfy | $19 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-10-16 | Cobenfy | $3 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-10-16 | Cobenfy | $4 |
| Otsuka America Pharmaceutical | Meals · 2025-10-13 | Abilify Asimtufii | $33 |
| Otsuka America Pharmaceutical | Meals · 2025-10-10 | Rexulti | $19 |
| Teva Pharmaceuticals USA | Meals · 2025-10-09 | Austedo Xr | $30 |
| Abbvie | Meals · 2025-10-07 | Vraylar | $11 |
| Abbvie | Meals · 2025-10-07 | Vraylar | $15 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-10-06 | Caplyta | $24 |
| Abbvie | Meals · 2025-09-30 | Vraylar | $31 |
| Otsuka America Pharmaceutical | Meals · 2025-09-17 | Abilify Asimtufii | $21 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-09-16 | Cobenfy | $17 |
| Abbvie | Meals · 2025-09-16 | Vraylar | $17 |
| Otsuka America Pharmaceutical | Meals · 2025-09-12 | Rexulti | $15 |
| Alkermes | Meals · 2025-08-29 | Aristada | $27 |
| Otsuka America Pharmaceutical | Meals · 2025-08-29 | Rexulti | $9 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-08-27 | Cobenfy | $11 |
| Otsuka America Pharmaceutical | Meals · 2025-08-27 | Abilify Asimtufii | $24 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-08-22 | Cobenfy | $15 |
| Teva Pharmaceuticals USA | Meals · 2025-08-20 | Austedo Xr | $32 |
| Otsuka America Pharmaceutical | Meals · 2025-08-15 | Rexulti | $15 |
| Abbvie | Meals · 2025-08-05 | Vraylar | $9 |
| Teva Pharmaceuticals USA | Meals · 2025-07-29 | Austedo Xr | $28 |
| Abbvie | Meals · 2025-07-23 | Vraylar | $18 |
| Otsuka America Pharmaceutical | Meals · 2025-07-23 | Abilify Maintena | $25 |
| Abbvie | Meals · 2025-07-18 | Vraylar | $22 |
| Otsuka America Pharmaceutical | Meals · 2025-07-18 | Rexulti | $15 |
| Abbvie | Meals · 2025-07-02 | Vraylar | $18 |
| Otsuka America Pharmaceutical | Meals · 2025-07-01 | Abilify Maintena | $18 |
| Otsuka America Pharmaceutical | Meals · 2025-06-13 | Rexulti | $17 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-06-10 | Cobenfy | $16 |
| Luye Pharma (USA) | Meals · 2025-06-07 | Erzofri Extended-Release | $23 |
| Otsuka America Pharmaceutical | Meals · 2025-05-30 | Rexulti | $11 |
| Otsuka America Pharmaceutical | Meals · 2025-05-30 | Rexulti | $18 |
| Abbvie | Meals · 2025-05-20 | Vraylar | $7 |
| Neurocrine BioSciences | Meals · 2025-05-20 | Ingrezza | $15 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-05-16 | Cobenfy | $16 |
| Janssen Pharmaceuticals | Meals · 2025-05-11 | Invega Sustenna | $24 |
| Abbvie | Meals · 2025-05-08 | Vraylar | $10 |
| Teva Pharmaceuticals USA | Meals · 2025-04-28 | Austedo Xr | $31 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-04-18 | Cobenfy | $5 |
| Otsuka America Pharmaceutical | Meals · 2025-04-18 | Rexulti | $4 |
| Teva Pharmaceuticals USA | Meals · 2025-04-18 | Austedo Xr | $30 |
| Otsuka America Pharmaceutical | Meals · 2025-04-15 | Abilify Maintena | $20 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-04-15 | Caplyta | $18 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-04-14 | Cobenfy | $14 |
| Teva Pharmaceuticals USA | Meals · 2025-04-09 | Uzedy | $29 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-04-08 | Cobenfy | $16 |
| Sage Therapeutics | Meals · 2025-03-18 | Zurzuvae | $24 |
| Otsuka America Pharmaceutical | Meals · 2025-01-28 | Abilify Maintena | $8 |
| Indivior | Meals · 2025-01-24 | Sublocade | $16 |
| Otsuka America Pharmaceutical | Meals · 2025-01-14 | Abilify Asimtufii | $21 |
See earlier years (2024, 2023, 2022)
2024: $112
| Janssen Pharmaceuticals | Spravato | $41 | 2 payments
|
| Teva Pharmaceuticals USA | Uzedy | $19 | 1 payment
|
| Neurocrine Biosciences | Ingrezza | $18 | 1 payment
|
| Alkermes | Aristada | $17 | 1 payment
|
| Otsuka America Pharmaceutical | Abilify Asimtufii | $17 | 1 payment
|
2023: $53
| Abbvie | Vraylar | $53 | 2 payments
|
2022: $40
| Abbvie | Vraylar | $40 | 2 payments
|
Professional record
- NPI
- 1497986285
- Licence
- CA A124839California A124839: Current · expires 2027-02-28
- Group
- Hisham Soliman MD Inc · Hazel Hawkins Memorial Hospital · St. Helena Hospital · Foundations Behavioral Health Services Inc · Ohioguidestone
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 2084P0804X (2084P0804X)
- Mailing address
- 510 Plaza Dr Ste 170, Folsom, CA, 95630
- NPI first listed
- 2009-07-28
- NPI last updated
- 2026-06-19
- NPI record certified
- 2026-06-19
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1101 Maidu Dr, Auburn, CA, 95603 · 5441 Aldrin Ct Ste A, Bakersfield, CA, 93313 · 2062 Talbert Dr Ste 100, Chico, CA, 95928 · 380 Coalinga Plz, Coalinga, CA, 93210 · 1245 W 6th St, Corona, CA, 92882 · 2345 Fletcher Pkwy, El Cajon, CA, 92020 · 9381 E Stockton Blvd Ste 220, Elk Grove, CA, 95624 · 15720 Ventura Blvd Ste 210, Encino, CA, 91436 · 622 Jackson St Unit 103, Fairfield, CA, 94533 · 44240 Fremont Blvd, Fremont, CA, 94538 · 4025 N Fresno St, Fresno, CA, 93726 · 801 E. Chapman Ave., Fullerton, CA, 92831 · 36618 Lassen Ave, Huron, CA, 93234 · 2955 Main St Ste 110-K, Irvine, CA, 92614 · 275 S Madera Ave Ste 404, Kerman, CA, 93630 · 121 Belmont Ave, Mendota, CA, 93640 · 509 13th St Ste 8, Modesto, CA, 95354 · 101 the City Dr S Bldg 3, Orange, CA, 92868 · 40 E Minarets Ave, Pinedale, CA, 93650 · 7365 Carnelian St Ste 222f, Rancho Cucamonga, CA, 91730 · 1311 11th St, Reedley, CA, 93654 · 7177 Brockton Ave Ste 444a, Riverside, CA, 92506 · 2440 Professional Dr, Roseville, CA, 95661 · 2386 Fair Oaks Blvd, Sacramento, CA, 95825 · 3108 Fulton Ave Ste 2, Sacramento, CA, 95821 · 225 W Hospitality Ln # 225201p, San Bernardino, CA, 92408 · 3200 4th Ave Ste 200g, San Diego, CA, 92103 · 1254 Mission St Ste 220, San Francisco, CA, 94103 · 225 Academy Ave, Sanger, CA, 93657 · 1040 Park Ave Ste 200-A, San Jose, CA, 95126 · 888 4th St Ste 12, San Rafael, CA, 94901 · 3400 Mccall Ave, Selma, CA, 93662 · 2222 Pacific Ave, Stockton, CA, 95204 · 525 Oregon St, Vallejo, CA, 94590 · 1372 N Main St Ste 206-1, Walnut Creek, CA, 94596 · 1501 W Cameron Ave Ste 300-129, West Covina, CA, 91790